Molecular docking analysis was conducted to explore the potential interactions between the primary blood-entry constituents of CF—androsin, cynaroside, and salicin and three key targets implicated in hyperuricemia: COX-1, PGE2, and XOD. The gene discussed is PTGS1; the disease is hyperuricemia.